Contact
searchSearch
HMP Global
Clinical Videos

Video Supplement: Modified Tunnel-in-Landslide Technique (TILT) Using Ping-Pong Guides

04/17/2026

Video 1. Successful passage of a 3.5 x 15-mm drug-eluting stent using modified “tunnel-in-landslide” technique (TILT).

Video 2. Final right coronary artery angiogram after 3.5 mm stents and 4.0-mm noncompliant balloon postdilatation.

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


Related Content

Clinical Images
Modified Tunnel-in-Landslide Technique (TILT) Using Ping-Pong Guides
04/17/2026
A 65-year-old man presented with unstable angina and calcified right coronary artery stenosis on diagnostic catheterization via radial approach. Percutaneous coronary intervention was performed via 7F femoral access using a Judkin’s Right 4...
A 65-year-old man presented with unstable angina and calcified right coronary artery stenosis on diagnostic catheterization via radial approach. Percutaneous coronary intervention was performed via 7F femoral access using a Judkin’s Right 4...
A 65-year-old man presented with...
04/17/2026
Journal of Invasive Cardiology
Ouerghi Figure
Clinical Videos
Mechanical Reperfusion of Subocclusive Plaque Erosion: 30-Month Outcome of an Optical Coherence Tomography-Guided Stentless Strategy
01/27/2026
Kaïs Ouerghi, MD; Tahar Lazizi, MD; Victor Mateus, MD
Video Supplement to "Mechanical Reperfusion of Subocclusive Plaque Erosion: 30-Month Outcome of an Optical Coherence Tomography-Guided Stentless Strategy" (Clinical Image).
Video Supplement to "Mechanical Reperfusion of Subocclusive Plaque Erosion: 30-Month Outcome of an Optical Coherence Tomography-Guided Stentless Strategy" (Clinical Image).
Video Supplement to "Mechanical...
01/27/2026
Journal of Invasive Cardiology
Clinical Images
Mechanical Reperfusion of Subocclusive Plaque Erosion: 30-Month Outcome of an Optical Coherence Tomography-Guided Stentless Strategy
01/27/2026
Kaïs Ouerghi, MD; Tahar Lazizi, MD; Victor Mateus, MD
A 28-year-old man with no cardiovascular risk factors presented with an acute anterior ST-elevation myocardial infarction at H+6 after strenuous physical exertion. Emergent angiography revealed a 99% subocclusive stenosis of the mid-left...
A 28-year-old man with no cardiovascular risk factors presented with an acute anterior ST-elevation myocardial infarction at H+6 after strenuous physical exertion. Emergent angiography revealed a 99% subocclusive stenosis of the mid-left...
A 28-year-old man with no...
01/27/2026
Journal of Invasive Cardiology
Yau Figure 1
Clinical Videos
Ventricular Fibrillation as a Manifestation of Delayed Distal Coronary Perforation Induced by High Blood Pressure
12/29/2025
Kwok-Ho Yau, MBBS; Tin Wah Christopher Lau, MBBS; Justin Ka-Ho Wong, MBBS; Kin-Lam Tsui, MBBS, FACC
Video Supplement to "Ventricular Fibrillation as a Manifestation of Delayed Distal Coronary Perforation Induced by High Blood Pressure" (Clinical Image).
Video Supplement to "Ventricular Fibrillation as a Manifestation of Delayed Distal Coronary Perforation Induced by High Blood Pressure" (Clinical Image).
Video Supplement to "Ventricular...
12/29/2025
Journal of Invasive Cardiology

News

ACC 2026
Boston Scientific Presents Two Late-Breaking Trials at ACC 2026 Highlighting New Evidence in Stroke Prevention for AFib and Treatment of Intermediate-Risk Pulmonary Embolism
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
Interventional Cardiology
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
03/25/2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional...
03/25/2026
Vascular Disease Management
Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Rob Williamson, RAMPART CRO
Industry Leaders
RAMPART Appoints Rob Williamson as Chief Revenue Officer
02/12/2026
As Chief Revenue Officer, Rob Williamson will lead Rampart’s U.S. Sales organization, focusing on revenue growth, field execution, and team expansion.
As Chief Revenue Officer, Rob Williamson will lead Rampart’s U.S. Sales organization, focusing on revenue growth, field execution, and team expansion.
As Chief Revenue Officer, Rob...
02/12/2026
Cath Lab Digest
AI + ECG
Study Shows AccurKardia’s AI-Enabled ECG Can Detect Aortic Stenosis Years Before Valve Replacement and Improve Mortality Risk Prediction
02/11/2026
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can...
02/11/2026
Cath Lab Digest
The Salus and Tallahassee Memorial HealthCare teams celebrate after the first AeroShield case.
Radiation Protection Systems
Tallahassee Memorial HealthCare Advances Cath Lab Safety Through First-in-the-World Technology Adoption
02/10/2026
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee...
02/10/2026
Cath Lab Digest
Thrombectomy
Avantec Vascular, a NIPRO Company, Announces FDA 510(k) Clearance of Thrombectomy System
02/10/2026
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California...
02/10/2026
Cath Lab Digest
Heart Disease and Flu
Mount Sinai Scientists Uncover Link Between Influenza and Heart Disease
02/09/2026
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai...
02/09/2026
Cath Lab Digest
Transseptal Access
AF Symposium 2026: New Data Show Atraverse Medical’s HOTWIRE™ System Mitigates Unintended Left Atrial Injury With Reduced RF Delivery
02/09/2026
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access...
02/09/2026
EP Lab Digest
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use